Toronto - Delayed Quote CAD

Burcon NutraScience Corporation (BU.TO)

Compare
0.1250 -0.0100 (-7.41%)
At close: November 1 at 1:41 p.m. EDT
Loading Chart for BU.TO
DELL
  • Previous Close 0.1350
  • Open 0.1350
  • Bid 0.1250 x --
  • Ask 0.1300 x --
  • Day's Range 0.1250 - 0.1350
  • 52 Week Range 0.1100 - 0.3500
  • Volume 8,838
  • Avg. Volume 33,083
  • Market Cap (intraday) 17.762M
  • Beta (5Y Monthly) 2.90
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2100
  • Earnings Date Nov 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company offers Peazazz and Peazac, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products; Puratein, a canola protein isolate use for meat alternatives, such as burgers, sausages, and nutrition bars; and Supertein, a canola protein for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows, and ready-to-mix beverages, whipped toppings, and plant-based bars. It also provides Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods; and CLARISOY, a soy protein for use in sports nutrition beverages, citrus-based drinks, fruit-flavored beverages, lemonades, powdered beverage mixes, and non-beverage plant-based products. In addition, the company offers hemp protein isolates. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. The company was incorporated in 1998 and is headquartered in Vancouver, Canada.

www.burcon.ca

25

Full Time Employees

March 31

Fiscal Year Ends

Consumer Defensive

Sector

Packaged Foods

Industry

Recent News: BU.TO

View More

Performance Overview: BU.TO

Trailing total returns as of 2024-11-01, which may include dividends or other distributions. Benchmark is

.

YTD Return

BU.TO
43.18%
S&P/TSX Composite index
15.73%

1-Year Return

BU.TO
13.64%
S&P/TSX Composite index
28.51%

3-Year Return

BU.TO
92.56%
S&P/TSX Composite index
15.30%

5-Year Return

BU.TO
86.98%
S&P/TSX Composite index
47.15%

Compare To: BU.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BU.TO

View More

Valuation Measures

As of 2024-11-01
  • Market Cap

    17.76M

  • Enterprise Value

    19.47M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    50.55

  • Price/Book (mrq)

    3.06

  • Enterprise Value/Revenue

    71.22

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -39.22%

  • Return on Equity (ttm)

    -159.36%

  • Revenue (ttm)

    420.98k

  • Net Income Avi to Common (ttm)

    -7.4M

  • Diluted EPS (ttm)

    -0.2100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.16M

  • Total Debt/Equity (mrq)

    187.90%

  • Levered Free Cash Flow (ttm)

    -4.17M

Research Analysis: BU.TO

View More

Revenue vs. Earnings

Revenue 236.62k
Earnings -1.87M
 

Analyst Price Targets

 

People Also Watch